UPDATE
: Wednesday, February 20, 2019
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Pfizer’s patent barrier foils Korea’s 1st pneumococcal conjugate vaccine
SK Bioscience’s Skypheumo, a pneumococcal conjugate vaccine (PCV) approval,...
by Lee Han-soo
|
2019-02-20 16:18
라인
FDA rejects Medytox’s ‘citizen petition’ against Daewoong
Daewoong Pharmaceutical said Wednesday that the FDA rejected Medytox’s “cit...
by Lee Han-soo
|
2019-02-20 14:37
라인
Court suspends FSC’s disciplinary action against Samsung BioLogics
The Seoul Administrative Court Tuesday suspended the Financial Services Com...
by Lee Han-soo
|
2019-02-20 12:12
라인
Chong Kun Dang unveils trial results for erectile dysfunction treatment
Chong Kun Dang said Monday that it has presented the clinical trial results...
by Lee Han-soo
|
2019-02-19 17:36
라인
Yuhan’s sales reached ₩1.5 trillion in 2018
Yuhan Corp. said Monday that it recorded 1.5 trillion won ($1.3 billion) in...
by Lee Han-soo
|
2019-02-19 16:06
라인
Pharma Research Bio wins nod to export botulinum toxin
Pharma Research Bio said it obtained approval from the Ministry of Food and...
by Lee Hye-seon
|
2019-02-19 15:46
라인
[News Focus] Will MSD’s new antidiabetic SGLT-2 inhibitor prove effective?
Whether MSD’s ertugliflozin, a new antidiabetic SGLT-2 (sodium-glucose cotr...
by Kim Yun-mi
|
2019-02-19 14:31
라인
Does anticoagulant Eliquis work on children?
The Ministry of Food and Drug Safety has allowed BMS Korea to conduct a pha...
by Lee Hye-seon
|
2019-02-19 10:53
라인
Technoclone to supply Handok diagnostic reagent for ADAMTS-13 activity test
Handok said Monday that it has signed an agreement with Technoclone, an Aus...
by Lee Han-soo
|
2019-02-18 16:38
라인
‘Hair loss drug Propesia works well for Koreans in long term’
MSD Korea’s Propesia (ingredient: finasteride), which has been used as male...
by Kim Yun-mi
|
2019-02-18 16:38
라인
Hanmi’s RaboneD dominates osteoporosis therapy market
Hanmi Pharmaceutical’s RaboneD, an osteoporosis treatment in the selective ...
by Kim Yun-mi
|
2019-02-18 14:23
라인
Humedix posts record-high sales in Q4 sales
Humedix said Friday that its earnings turned around and has posted record-h...
by Lee Han-soo
|
2019-02-18 14:22
라인
Ministry OKs Peptron’s P2 clinical trial of Parkinson’s disease treatment
Peptron said Monday that the Ministry of Food and Drug Safety has approved ...
by Lee Han-soo
|
2019-02-18 11:13
라인
Sillajen’s research selected as cover paper for international journal
Sillajen said Friday that the Clinical Cancer Research, an international jo...
by Lee Han-soo
|
2019-02-15 17:36
라인
SK Biopharmaceuticals, Arvelle to develop, commercialize cenobamate in Europe
SK Biopharmaceuticals said Thursday that it has signed an exclusive licensi...
by Lee Han-soo
|
2019-02-15 15:36
라인
Acute myeloid leukemia treatment Rydapt approved as orphan drug
The regulatory agency approved Rydapt 25mg (ingredient: midostaurin), a tre...
by Lee Hye-seon
|
2019-02-15 15:36
라인
Sanofi Genzyme Korea launches rare blood disorder franchise
Sanofi Genzyme Korea, a subsidiary of Sanofi, said Thursday that it has lau...
by Lee Han-soo
|
2019-02-15 14:37
라인
GC starts P2 trials of hepatitis B treatment
GC said Thursday that it has administered the first dose of GC1102, a new r...
by Lee Han-soo
|
2019-02-15 14:36
라인
MSD leads rapidly growing antidiabetic DPP-4 inhibitors market
MSD took the No. 1 position in sales of antidiabetic dipeptidyl peptidase-4...
by Kim Yun-mi
|
2019-02-15 14:31
라인
Dong-A ST posts ₩567.2 billion in 2018 sales
Dong-A ST said Wednesday that it recorded the sales of 567.2 billion ($504....
by Lee Han-soo
|
2019-02-14 16:13
-
1
2
3
4
5
6
7
8
9
10
다음
-
Ewha Medical Center, LG U+ open Korea’s 1st ‘smart sleeping room’
Regulator to inspect 12 biopharmaceutical plants overseas
Pfizer’s patent barrier foils Korea’s 1st pneumococcal conjugate vaccine
‘Menopausal hormone therapy can reduce mortality’
Ewha Medical Center, LG U+ open Korea’s 1st ‘smart sleeping room’
Regulator to inspect 12 biopharmaceutical plants overseas
Pfizer’s patent barrier foils Korea’s 1st pneumococcal conjugate vaccine
‘Menopausal hormone therapy can reduce mortality’
여백
Most viewed
1
Direct-acting antivirals reduce death risk for hepatitis C patients: study
2
Sillajen’s research selected as cover paper for international journal
3
Sanofi Genzyme Korea launches rare blood disorder franchise
4
‘Hair loss drug Propesia works well for Koreans in long term’
5
Korean researchers find gene responsible for extremely rare disease
6
Fine dust has lag effects on people with respiratory illnesses: report
7
Regulators fine Smith & Nephew for providing rebates
8
MSD leads rapidly growing antidiabetic DPP-4 inhibitors market
9
Korea sets guideline for pediatric obesity treatment for 1st time in Asia
10
Blood-thinning NOAC market expands 30% in 2018
여백
Opinion
[Reporter’s Notebook] TV dramas misportray mental hospitals
[Column] Patient stabbed doctor to death -- things can’t just go on like this
[Column]Korea’s healthcare industry; do flowers blossom in desert, too?
여백
Back to Top